Site Search
Company Search
Get Quote
The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™
SeriousTradersSpotlight Company
BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF)
Investment Considerations Flagship drug candidate BNT23001 targets the $28B MS market with a faster-acting, easier-to-administer sublingual format. Additional candidates address MG, LN, RA, longevity, and diabetes/obesity using the same thin-film technology. Gen-Plus R&D integration accelerates development, manufacturing, and European commercialization. Patent portfolio spans major global markets with flagship claims validated by the European Patent Office. … Continue reading “BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF)”
Latest Press Releases
Filter Releases
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |
SeriousTraders is part of the IBN (InvestorBrandNetwork). Other brands within the investor brand network include:
